Stay updated on Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.

Latest updates to the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page
- Check4 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the page's history and the previous entry v3.5.3 was removed.SummaryDifference0.1%

- Check11 days agoChange DetectedUpdated the study record to Completed with Results Posted, including Adverse Events, Outcome Measures (Results), Participant Flow, and Recruitment/Study Status. The previous Active, not recruiting and Results Submitted entries were removed, reflecting the trial's completion and public availability of final data.SummaryDifference0.8%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer/interface version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check40 days agoChange DetectedThe latest version adds multiple study-record sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Design, Study Status) and marks 'Returned' on 2026-04-07, with Quality Control status noted as not concluded.SummaryDifference0.9%

- Check62 days agoChange DetectedResults status changed from No Results Posted to Results Submitted. Revision updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

Stay in the know with updates to Vemurafenib Combo in High-Risk Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib Combo in High-Risk Melanoma Clinical Trial page.